Viewing Study NCT04427293


Ignite Creation Date: 2025-12-25 @ 1:15 AM
Ignite Modification Date: 2025-12-25 @ 11:24 PM
Study NCT ID: NCT04427293
Status: RECRUITING
Last Update Posted: 2025-12-16
First Post: 2020-06-08
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Preoperative Lenvatinib Plus Pembrolizumab in Early-Stage Triple-Negative Breast Cancer (TNBC)
Sponsor: University of Illinois at Chicago
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module